Skip to content

Validation of Accexible as a Tool for Screening and Monitoring Depression.

Validación Del Sistema de Cribaje y Seguimiento de acceXible Para depresión.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06044818
Enrollment
166
Registered
2023-09-21
Start date
2023-07-10
Completion date
2025-04-17
Last updated
2026-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major Depressive Disorder (MDD)

Brief summary

Major depressive disorder (MDD) is a chronic disease with a prevalence around 8-12% and is considered one of the most debilitating disease worldwide. A recent orientation is the analysis of language in relation to the description of images with a high and varied semantic and emotional content. It can be studied that changes in the description of an image check if these changes are associated with the evolution of a person with probable impairment both in memory and cognitive as well as emotional, psychiatric, behavioral and even in their interaction with environmental factors especially those associated with socialization and loneliness. The present study has the objective of validating Accexible as a tool for Screening and Monitoring Depression.

Interventions

DEVICEAccexible

Speech Analysis

Sponsors

Accexible
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Adult 18-65 years of age. * Participants must have Spanish as their first language (able to speak and understand verbal messages). * Participants must have mobile phone with internet. * Participants must have the ability to understand AcceXible's basic instructions. * Participants must agree to participate in the study and have voluntarily signed the informed consent.

Exclusion criteria

for patients: * To have received a diagnosis of neurodegeneration. * To have significant vision problems that would affect the ability to perceive visual stimuli. * To have significant hearing problems that would affect the ability to understand verbal cues. * To be unable to give informed consent to participate in the study.

Design outcomes

Primary

MeasureTime frameDescription
Prevalence of DepressionAn average of 1 yearquestionnaire

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 26, 2026